Epicardium-derived cells are important for correct development of the Purkinje fibers in the avian heart.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101234285 Publication Model: Print Cited Medium: Print ISSN: 1552-4884 (Print) Linking ISSN: 15524884 NLM ISO Abbreviation: Anat Rec A Discov Mol Cell Evol Biol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Hoboken, NJ : Wiley-Liss, c2003-c2006.
    • Subject Terms:
      Cell Differentiation*; Heart/*embryology ; Pericardium/*pathology ; Purkinje Fibers/*pathology; Animals ; Cell Communication ; Cell Movement ; Cell Shape ; Chick Embryo ; Chickens ; Coturnix ; DNA, Antisense/genetics ; DNA, Antisense/metabolism ; Pericardium/embryology ; Proto-Oncogene Protein c-ets-1/genetics ; Proto-Oncogene Protein c-ets-1/metabolism ; Proto-Oncogene Protein c-ets-2/genetics ; Proto-Oncogene Protein c-ets-2/metabolism ; Purkinje Fibers/embryology ; Stress, Mechanical
    • Abstract:
      During embryonic development, the proepicardial organ (PEO) grows out over the heart surface to form the epicardium. Following epithelial-mesenchymal transformation, epicardium-derived cells (EPDCs) migrate into the heart and contribute to the developing coronary arteries, to the valves, and to the myocardium. The peripheral Purkinje fiber network develops from differentiating cardiomyocytes in the ventricular myocardium. Intrigued by the close spatial relationship between the final destinations of migrating EPDCs and Purkinje fiber differentiation in the avian heart, that is, surrounding the coronary arteries and at subendocardial sites, we investigated whether inhibition of epicardial outgrowth would disturb cardiomyocyte differentiation into Purkinje fibers. To this end, epicardial development was inhibited mechanically with a membrane, or genetically, by suppressing epicardial epithelial-to-mesenchymal transformation with antisense retroviral vectors affecting Ets transcription factor levels (n=4, HH39-41). In both epicardial inhibition models, we evaluated Purkinje fiber development by EAP-300 immunohistochemistry and found that restraints on EPDC development resulted in morphologically aberrant differentiation of Purkinje fibers. Purkinje fiber hypoplasia was observed both periarterially and at subendocardial positions. Furthermore, the cells were morphologically abnormal and not aligned in orderly Purkinje fibers. We conclude that EPDCs are instrumental in Purkinje fiber differentiation, and we hypothesize that they cooperate directly with endothelial and endocardial cells in the development of the peripheral conduction system.
      (Copyright (c) 2006 Wiley-Liss, Inc.)
    • References:
      Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6815-8. (PMID: 9618495)
      Circ Res. 1998 Jun 1;82(10):1043-52. (PMID: 9622157)
      Development. 1998 Oct;125(19):3809-20. (PMID: 9729489)
      Anat Embryol (Berl). 1999 Apr;199(4):367-78. (PMID: 10195310)
      Anat Rec A Discov Mol Cell Evol Biol. 2005 Feb;282(2):120-9. (PMID: 15627984)
      Circ Res. 2005 Mar 18;96(5):526-34. (PMID: 15705966)
      J Morphol. 1951 Jan;88(1):49-92. (PMID: 24539719)
      Circ Res. 2003 Apr 18;92(7):749-56. (PMID: 12637368)
      Circ Res. 2003 Jul 11;93(1):77-85. (PMID: 12775585)
      Dev Dyn. 2003 Aug;227(4):511-23. (PMID: 12889060)
      Novartis Found Symp. 2003;250:110-22; discussion 122-4, 276-9. (PMID: 12956326)
      Novartis Found Symp. 2003;250:125-34; discussion 134-41, 276-9. (PMID: 12956327)
      Anat Rec A Discov Mol Cell Evol Biol. 2003 Dec;275(2):1109-16. (PMID: 14613310)
      Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13214-8. (PMID: 10557300)
      Cell. 2000 Jun 23;101(7):729-39. (PMID: 10892744)
      Development. 2000 Aug;127(16):3523-32. (PMID: 10903177)
      Circ Res. 2000 Nov 24;87(11):969-71. (PMID: 11090540)
      Dev Dyn. 2002 Jan;223(1):119-33. (PMID: 11803575)
      Dev Dyn. 2002 Apr;223(4):469-82. (PMID: 11921336)
      Development. 2004 Feb;131(3):581-92. (PMID: 14711873)
      Anat Embryol (Berl). 1993 Mar;187(3):281-9. (PMID: 8470828)
      Circ Res. 1993 Sep;73(3):559-68. (PMID: 8348697)
      Anat Embryol (Berl). 1993 Oct;188(4):381-93. (PMID: 7506502)
      J Cardiovasc Pharmacol. 1994 Nov;24(5):715-20. (PMID: 7532748)
      Development. 1995 Feb;121(2):489-503. (PMID: 7539357)
      Development. 1995 Feb;121(2):549-60. (PMID: 7539359)
      Development. 1995 May;121(5):1423-31. (PMID: 7789272)
      Dev Dyn. 1995 May;203(1):51-60. (PMID: 7647374)
      Dev Dyn. 1997 Mar;208(3):338-48. (PMID: 9056638)
      Dev Dyn. 1998 Jul;212(3):373-84. (PMID: 9671941)
    • Grant Information:
      P01 HD039946-05 United States HD NICHD NIH HHS; HL56728-09 United States HL NHLBI NIH HHS; R01 HL056728 United States HL NHLBI NIH HHS; HD39946-05 United States HD NICHD NIH HHS; P01 HD039946 United States HD NICHD NIH HHS
    • Accession Number:
      0 (DNA, Antisense)
      0 (Proto-Oncogene Protein c-ets-1)
      0 (Proto-Oncogene Protein c-ets-2)
    • Publication Date:
      Date Created: 20061101 Date Completed: 20070215 Latest Revision: 20181113
    • Publication Date:
      20240829
    • Accession Number:
      PMC2610390
    • Accession Number:
      10.1002/ar.a.20398
    • Accession Number:
      17075847